Artificial, non-antibody binding proteins for pharmaceutical and industrial applications
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 23 (10) , 514-522
- https://doi.org/10.1016/j.tibtech.2005.07.007
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Single Domain Antibodies Derived from Dromedary Lymph Node and Peripheral Blood Lymphocytes Sensing Conformational Variants of Prostate-specific AntigenJournal of Biological Chemistry, 2004
- Intrabodies: production and promiseDrug Discovery Today, 2004
- Second-generation biopharmaceuticalsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Next-generation protein drugsNature Biotechnology, 2004
- Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugatesAdvanced Drug Delivery Reviews, 2003
- Design and Characterization of a Hybrid Miniprotein That Specifically Inhibits Porcine Pancreatic ElastasePublished by Elsevier ,2003
- A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigeninJournal of Molecular Biology, 2000
- Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999
- The fibronectin type III domain as a scaffold for novel binding proteinsJournal of Molecular Biology, 1998
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990